Mapping rare, deleterious mutations in Factor H: Association with early onset, drusen burden, and lower antigenic levels in familial AMD.

Sci Rep
Authors
Abstract

The genetic architecture of age-related macular degeneration (AMD) involves numerous genetic variants, both common and rare, in the coding region of complement factor H (CFH). While these variants explain high disease burden in some families, they fail to explain the pathology in all. We selected families whose AMD was unexplained by known variants and performed whole exome sequencing to probe for other rare, highly penetrant variants. We identified four rare loss-of-function variants in CFH associated with AMD. Missense variant CFH 1:196646753 (C192F) segregated perfectly within a family characterized by advanced AMD and drusen temporal to the macula. Two families, each comprising a pair of affected siblings with extensive extramacular drusen, carried essential splice site variant CFH 1:196648924 (IVS6+1G>A) or missense variant rs139360826 (R175P). In a fourth family, missense variant rs121913058 (R127H) was associated with AMD. Most carriers had early onset bilateral advanced AMD and extramacular drusen. Carriers tended to have low serum Factor H levels, especially carriers of the splice variant. One missense variant (R127H) has been previously shown not to be secreted. The two other missense variants were produced recombinantly: compared to wild type, one (R175P) had no functional activity and the other (C192F) had decreased secretion.

Year of Publication
2016
Journal
Sci Rep
Volume
6
Pages
31531
Date Published
2016 Aug 30
ISSN
2045-2322
DOI
10.1038/srep31531
PubMed ID
27572114
PubMed Central ID
PMC5004131
Links
Grant list
U01 HG007690 / HG / NHGRI NIH HHS / United States
U01 GM092691 / GM / NIGMS NIH HHS / United States
P30 AR048335 / AR / NIAMS NIH HHS / United States
R01 EY011309 / EY / NEI NIH HHS / United States
F30 HL103072 / HL / NHLBI NIH HHS / United States
R01 AR063759 / AR / NIAMS NIH HHS / United States
U54 HL112303 / HL / NHLBI NIH HHS / United States
R01 AI041592 / AI / NIAID NIH HHS / United States